Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,762 across all filing types
Latest filing 2023-12-19 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Intimation of issue of duplicate share certificates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchanges (BSE and NSE) informing about the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is a formal notification about share certificate issuance, not a financial report, earnings release, or management discussion. The document length is short (1940 characters) and it is an announcement of a corporate action related to shares but not a capital raising or share issue event. It does not fit into categories like Share Issue/Capital Change (SHA) because it is about duplicate certificates, not new shares or capital changes. It is not a Director's Dealing or Major Shareholding Notification. The best fitting category is Regulatory Filings (RNS), which is a fallback for miscellaneous regulatory announcements that do not fit other categories.
2023-12-19 English
Partial redemption of NCDs issued under ISIN - INE685A07082
Capital/Financing Update Classification · 100% confidence The document is a formal letter dated 14th December 2023 from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE) regarding the partial redemption of Non-Convertible Debentures (NCDs). It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an update on a financing activity — the redemption and repayment of a portion of the company's NCDs. There are no financial statements or detailed financial analysis present, only an announcement of a capital structure event. This fits the category of Capital/Financing Update (CAP). The document length is short and focused solely on this update, confirming it is not a full report or regulatory filing of another type.
2023-12-14 English
Redemption
Capital/Financing Update Classification · 95% confidence The document is a formal letter dated 14th December 2023 from Torrent Pharmaceuticals Limited, addressed to stock exchanges (BSE and NSE) with their respective scrip codes. It informs about the partial redemption of Non-Convertible Debentures (NCDs) worth 142.86 crores out of a total 1000 crores issued. The letter references compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an update on a financing activity (redemption of debt securities), not a full financial report or earnings release. The document length is short (1341 characters), and it is a direct announcement of a capital structure event (partial redemption of NCDs). Therefore, it fits best under Capital/Financing Update (CAP).
2023-12-14 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding an update under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about a USFDA Pre-Approval Inspection at the company's manufacturing facility and the issuance of a Form 483 with procedural observations. The document is an announcement of a regulatory event related to compliance and inspection results, not a financial report or detailed management discussion. The document length is short (2490 characters) and it serves as an intimation or regulatory announcement rather than a full report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-12-12 English
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges (BSE and NSE) regarding a regulatory update about a USFDA Pre-Approval Inspection at the company's manufacturing facility. It mentions the issuance of a Form 483 with procedural observations and the company's intention to respond. The document is short (2490 characters) and serves as an intimation or announcement under SEBI regulations, not a detailed report or financial statement. There is no financial data, no detailed report, or presentation. This fits the category of a Regulatory Filing (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2023-12-12 English
Intimation of Loss of Share Certificates
Regulatory Filings
2023-12-06 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.